课题基金 / 基金详情

Improving treatment efficacy: A randomized controlled trial of the combined used of intranasal oxytocin and cognitive behavioral therapy for the treatment of major depressive disorder

Improving treatment efficacy: A randomized controlled trial of the combined used of intranasal oxytocin and cognitive behavioral therapy for the treatment of major depressive disorder
提高治疗效果：鼻内催产素联合认知行为疗法治疗重度抑郁症的随机对照试验
批准号：
358659
负责人：
Ellenbogen Mark A
金额：
$50.71万
依托单位：
Concordia University (Montreal, Quebec)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2016
资助国家：
加拿大
项目状态：
已结题
起止时间：
2016-10-01 至 2021-10-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=358659&lang=en
关键词：
Cognitive-Behavioural Therapy Epigenetics Eye Tracking Information Processing Intranasal Oxytocin Major Depressive Disorder Psychotherapy Randomized Controlled Trial

项目摘要

项目成果

Ellenbogen Mark A的其他基金

相似基金

相关文献

中文摘要
翻译
重度抑郁症（MD）是复发性的，使人衰弱的，在某种程度上，是一种慢性疾病，尽管治疗取得了许多进展。虽然药物和心理治疗都被认为是有效的短期治疗MD，
英文摘要
Major depressive disorder (MD) is recurrent, debilitating, and, to some extent, a chronic disorder, despite the many advances in treatment. Although both drug and psychological treatments are considered to be efficacious in the short-term treatment of MD,
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The social information processing response to intranasal oxytocin as a potential marker of social vulnerability and risk for depression
The social information processing response to intranasal oxytocin as a potential marker of social vulnerability and risk for depression
海外基金